Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2006 Feb;61(2):98-9.
doi: 10.1136/thx.2005.047936.

Is EGFR expression important in non-small cell lung cancer?

S M Lee
Editorial

Is EGFR expression important in non-small cell lung cancer?

S M Lee. Thorax. 2006 Feb.

Abstract

There are still many unanswered questions on the use of EGFR treatment in NSCLC

PubMed Disclaimer

Conflict of interest statement

Competing interests: none declared

Comment on

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hirsch F R, Varella‐Garcia M, Bunn P A., Jret al Epidermal growth factor receptor in non‐small‐cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol 2003213798–3807. - PubMed
    1. Nakamura H, Kawasaki N, Taguchi M.et al Survival impact of epidermal growth factor receptor overexpression in patients with non‐small‐cell lung cancer: a meta‐analysis. Thorax 200661140–145. - PMC - PubMed
    1. Shigematsu H, Lin L, Takahashi T.et al Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 200597339–346. - PubMed
    1. Shepherd F A, Pereira J, Ciuleanu T E.et al Erlotinib in previously treated non‐small‐cell lung cancer. N Engl J Med 2005353123–132. - PubMed
    1. Fukuoka M, Yano S, Giaccone G.et al Multi‐institutional randomised phase II trial of gefitinib for previously treated patients with advanced non‐small cell lung cancer (the IDEAL 1 Trial). J Clin Oncol 2003212237–2246. - PubMed

MeSH terms